Peptide-nanoparticle conjugates as a theranostic platform

Funkhouser, 2002, Reinventing pharma: the theranostic revolution, Curr. Drug Discov., 2, 17 Kelkar, 2011, Theranostics: Combining Imaging and Therapy, Bioconjug. Chem., 22, 1879, 10.1021/bc200151q Wang, 2012, Nanotheranostics–a review of recent publications, Int. J. Nanomedicine, 7, 4679 Vargason, 2021, The evolution of commercial drug delivery technologies, Nat. Biomed. Eng., 5, 951, 10.1038/s41551-021-00698-w Lee, 2018, Molecular targeted therapy: Treating cancer with specificity, Eur. J. Pharmacol., 834, 188, 10.1016/j.ejphar.2018.07.034 Chames, 2009, Therapeutic antibodies: successes, limitations and hopes for the future, Br. J. Pharmacol., 157, 220, 10.1111/j.1476-5381.2009.00190.x Fleuren, 2014, Theranostic applications of antibodies in oncology, Mol. Oncol., 8, 799, 10.1016/j.molonc.2014.03.010 Shah, 2021, The Current Landscape of Antibody-based Therapies in Solid Malignancies, Theranostics, 11, 1493, 10.7150/thno.52614 Turner, 2018, Recent advances in theranostics and challenges for the future, Br. J. Radiol., 91, 20170893, 10.1259/bjr.20170893 Li, 2019, Small molecules as theranostic agents in cancer immunology, Theranostics, 9, 7849, 10.7150/thno.37218 Prasad, 2018, Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world, Biomed. Pharmacother., 97, 1521, 10.1016/j.biopha.2017.11.026 Lim, 2015, Nanomaterials for Theranostics: Recent Advances and Future Challenges, Chem. Rev., 115, 327, 10.1021/cr300213b Donahue, 2019, Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine, Adv. Drug Deliv. Rev., 143, 68, 10.1016/j.addr.2019.04.008 Kim, 2010, Nanomedicine, N. Eng. J. Med., 363, 2434, 10.1056/NEJMra0912273 Xie, 2010, Nanoparticle-based theranostic agents, Adv. Drug Deliv. Rev., 62, 1064, 10.1016/j.addr.2010.07.009 Janib, 2010, Imaging and drug delivery using theranostic nanoparticles, Adv. Drug Deliv. Rev., 62, 1052, 10.1016/j.addr.2010.08.004 Mitchell, 2021, Engineering precision nanoparticles for drug delivery, Nat. Rev. Drug Discov., 20, 101, 10.1038/s41573-020-0090-8 Kou, 2018, Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types, Front. Pharmacol., 9, 10.3389/fphar.2018.00027 Blanco, 2015, Principles of nanoparticle design for overcoming biological barriers to drug delivery, Nat. Biotechnol., 33, 941, 10.1038/nbt.3330 Peer, 2007, Nanocarriers as an emerging platform for cancer therapy, Nat. Nanotechnol., 2, 751, 10.1038/nnano.2007.387 Mitragotri, 2017, Drug Delivery Research for the Future: Expanding the Nano Horizons and Beyond, J. Control. Release, 246, 183, 10.1016/j.jconrel.2017.01.011 Wechsler, 2019, 110(th) Anniversary: Nanoparticle mediated drug delivery for the treatment of Alzheimer's disease: Crossing the blood-brain barrier, Ind. Eng. Chem. Res., 58, 15079, 10.1021/acs.iecr.9b02196 Björnmalm, 2017, Bridging Bio-Nano Science and Cancer Nanomedicine, ACS Nano, 11, 9594, 10.1021/acsnano.7b04855 Rosenblum, 2018, Progress and challenges towards targeted delivery of cancer therapeutics, Nat. Commun., 9, 1410, 10.1038/s41467-018-03705-y Alexis, 2008, Factors affecting the clearance and biodistribution of polymeric nanoparticles, Mol. Pharm., 5, 505, 10.1021/mp800051m Zhu, 2022, Nanomedicine: controlling nanoparticle clearance for translational success, Trends Pharmacol. Sci., 43, 709, 10.1016/j.tips.2022.05.001 Malachowski, 2020, Engineering nanoparticles to overcome immunological barriers for enhanced drug delivery, Eng. Regen., 1, 35 Boraschi, 2017, Nanoparticles and innate immunity: new perspectives on host defence, Semin. Immunol., 34, 33, 10.1016/j.smim.2017.08.013 Minelli, 2010, Engineering Nanocomposite Materials for Cancer Therapy, Small, 6, 2336, 10.1002/smll.201000523 Wang, 2021, Multifunctional biomolecule nanostructures for cancer therapy, Nat. Rev. Mater., 6, 766, 10.1038/s41578-021-00315-x Davis, 2008, Nanoparticle therapeutics: an emerging treatment modality for cancer, Nat. Rev. Drug Discov., 7, 771, 10.1038/nrd2614 Yoo, 2019, Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems, Cancers (basel), 11, 10.3390/cancers11050640 Pearce, 2019, Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine, Bioconjug. Chem., 30, 2300, 10.1021/acs.bioconjchem.9b00456 Spicer, 2018, Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications, Chem. Soc. Rev., 47, 3574, 10.1039/C7CS00877E Jeong, 2018, Peptide-nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms?, Nano Converg., 5, 38, 10.1186/s40580-018-0170-1 Cooper, 2021, Peptides as a platform for targeted therapeutics for cancer: peptide-drug conjugates (PDCs), Chem. Soc. Rev., 50, 1480, 10.1039/D0CS00556H Wang, 2017, Peptide-drug conjugates as effective prodrug strategies for targeted delivery, Adv. Drug Deliv. Rev., 110, 112, 10.1016/j.addr.2016.06.015 Khan, 2019, Nanoparticles: Properties, applications and toxicities, Arab. J. Chem., 12, 908, 10.1016/j.arabjc.2017.05.011 Albanese, 2012, The effect of nanoparticle size, shape, and surface chemistry on biological systems, Annu. Rev. Biomed. Eng., 14, 1, 10.1146/annurev-bioeng-071811-150124 Bobo, 2016, Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date, Pharm. Res., 33, 2373, 10.1007/s11095-016-1958-5 Waring, 2015, An analysis of the attrition of drug candidates from four major pharmaceutical companies, Nat. Rev. Drug Discov., 14, 475, 10.1038/nrd4609 Aryal, 2019, Top-down fabrication-based nano/microparticles for molecular imaging and drug delivery, Int. J. Nanomed., 14, 6631, 10.2147/IJN.S212037 Hao, 2016, The evaluation of cellular uptake efficiency and tumor-targeting ability of MPEG–PDLLA micelles: effect of particle size, RSC Adv., 6, 13698, 10.1039/C5RA26563K Zhang, 2018, Generation of Well-Defined Micro/Nanoparticles via Advanced Manufacturing Techniques for Therapeutic Delivery, Materials., 11, 623, 10.3390/ma11040623 Zaki, 2011, Nanocarriers for Cytoplasmic Delivery: Cellular Uptake and Intracellular Fate of Chitosan and Hyaluronic Acid-Coated Chitosan Nanoparticles in a Phagocytic Cell Model, Macromol. Biosci., 11, 1747, 10.1002/mabi.201100156 de Lazaro, 2021, Obstacles and opportunities in a forward vision for cancer nanomedicine, Nat. Mater., 20, 1469, 10.1038/s41563-021-01047-7 Shi, 2017, Cancer nanomedicine: progress, challenges and opportunities, Nat. Rev. Cancer, 17, 20, 10.1038/nrc.2016.108 Bajpai, 2021, Recent Advances in Nanoparticle-Based Cancer Treatment: A Review, ACS Appl. Nano Mater., 4, 6441, 10.1021/acsanm.1c00779 Lammers, 2011, Theranostic Nanomedicine, Acc. Chem. Res., 44, 1029, 10.1021/ar200019c Massoud, 2003, Molecular imaging in living subjects: seeing fundamental biological processes in a new light, Genes Dev., 17, 545, 10.1101/gad.1047403 Shu, 2013, Peptide-polymer conjugates: from fundamental science to application, Annu. Rev. Phys. Chem., 64, 631, 10.1146/annurev-physchem-040412-110108 Habibi, 2016, Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery, Nano Today, 11, 41, 10.1016/j.nantod.2016.02.004 Jeong, 2018, Modular Self-Assembling Peptide Platform with a Tunable Thermoresponsiveness via a Single Amino Acid Substitution, Adv. Funct. Mater., 28, 1803114, 10.1002/adfm.201803114 Weinstock, 2012, Protease-resistant peptide design-empowering nature's fragile warriors against HIV, Biopolymers, 98, 431, 10.1002/bip.22073 Klein, 2017, Stabilized helical peptides: overview of the technologies and its impact on drug discovery, Expert Opin. Drug Discov., 12, 1117, 10.1080/17460441.2017.1372745 Talmadge, 1998, Pharmacodynamic aspects of peptide administration biological response modifiers, Adv. Drug Deliv. Rev., 33, 241, 10.1016/S0169-409X(98)00032-5 Kitov, 2003, On the Nature of the Multivalency Effect: A Thermodynamic Model, J. Am. Chem. Soc., 125, 16271, 10.1021/ja038223n Gargano, 2001, Multivalent Inhibition of AB5 Toxins, J. Am. Chem. Soc., 123, 12909, 10.1021/ja016305a Hong, 2007, The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform, Chem. Biol., 14, 107, 10.1016/j.chembiol.2006.11.015 Martinez-Veracoechea, 2011, Designing super selectivity in multivalent nano-particle binding, Proc. Natl. Acad. Sci. u. s. a., 108, 10963, 10.1073/pnas.1105351108 Vauquelin, 2010, Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action, Br. J. Pharmacol., 161, 488, 10.1111/j.1476-5381.2010.00936.x Liu, 2016, Revisiting the classification of NIR-absorbing/emitting nanomaterials for in vivo bioapplications, NPG Asia Mater., 8, e295, 10.1038/am.2016.106 Lucky, 2015, Nanoparticles in photodynamic therapy, Chem. Rev., 115, 1990, 10.1021/cr5004198 Emelianov, 2009, Photoacoustics for molecular imaging and therapy, Phys. Today, 62, 34, 10.1063/1.3141939 Bogusz, 2018, High toxicity of Bi(OH)3 and alpha-Bi2O3 nanoparticles towards malignant 9L and MCF-7 cells, Mater. Sci. Eng. c., 93, 958, 10.1016/j.msec.2018.09.001 Hsu, 2021, Oxi-Redox Selective Breast Cancer Treatment: An In Vitro Study of Theranostic In-Based Oxide Nanoparticles for Controlled Generation or Prevention of Oxidative Stress, ACS Appl. Mater. Interfaces, 13, 2204, 10.1021/acsami.0c17326 Bogusz, 2014, Synthesis of potential theranostic system consisting of methotrexate-immobilized (3-aminopropyl)trimethoxysilane coated alpha-Bi2O3 nanoparticles for cancer treatment, RSC Adv., 4, 24412, 10.1039/c4ra02160f Kudr, 2017, Magnetic Nanoparticles: From Design and Synthesis to Real World Applications, Nanomaterials, 7, 10.3390/nano7090243 McBain, 2008, Magnetic nanoparticles for gene and drug delivery, Int. J. Nanomedicine, 3, 169 Wang, 2022, Therapeutic peptides: current applications and future directions, Signal Transduct. Target. Ther., 7, 48, 10.1038/s41392-022-00904-4 Lau, 2018, Therapeutic peptides: Historical perspectives, current development trends, and future directions, Bioorg. Med. Chem., 26, 2700, 10.1016/j.bmc.2017.06.052 Craik, 2013, The future of peptide-based drugs, Chem. Biol. Drug Des., 81, 136, 10.1111/cbdd.12055 Padhi, 2014, Antimicrobial peptides and proteins in mycobacterial therapy: Current status and future prospects, Tuberculosis, 94, 363, 10.1016/j.tube.2014.03.011 Buchwald, 2014, Effects on GLP-1, PYY, and leptin by direct stimulation of terminal ileum and cecum in humans: implications for ileal transposition, Surg. Obes. Relat. Dis., 10, 780, 10.1016/j.soard.2014.01.032 Giordano, 2014, Tirofiban induces VEGF production and stimulates migration and proliferation of endothelial cells, Vascul. Pharmacol., 61, 63, 10.1016/j.vph.2014.04.002 Robinson, 2014, Diversity of Conotoxin Gene Superfamilies in the Venomous Snail, Conus victoriae, PLoS One, 9, e87648, 10.1371/journal.pone.0087648 Fosgerau, 2015, Peptide therapeutics: current status and future directions, Drug Discov. Today, 20, 122, 10.1016/j.drudis.2014.10.003 Hamley, 2017, Small Bioactive Peptides for Biomaterials Design and Therapeutics, Chem. Rev., 117, 14015, 10.1021/acs.chemrev.7b00522 Giordano, 2014, Neuroactive Peptides as Putative Mediators of Antiepileptic Ketogenic Diets, Front. Neurol., 5, 63, 10.3389/fneur.2014.00063 Davda, 2019, Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics, J. Immunother. Cancer, 7, 105, 10.1186/s40425-019-0586-0 Waldmann, 2014, Human monoclonal antibodies: the residual challenge of antibody immunogenicity, Methods Mol. Biol., 1060, 1, 10.1007/978-1-62703-586-6_1 Petta, 2016, Modulation of Protein-Protein Interactions for the Development of Novel Therapeutics, Mol. Ther., 24, 707, 10.1038/mt.2015.214 Lee, 2019, A Comprehensive Review on Current Advances in Peptide Drug Development and Design, Int. J. Mol. Sci., 20, 2383, 10.3390/ijms20102383 Hill, 2014, Constraining cyclic peptides to mimic protein structure motifs, Angew. Chem. Int., 53, 13020, 10.1002/anie.201401058 Nevola, 2015, Modulating protein-protein interactions: the potential of peptides, Chem. Comm., 51, 3302, 10.1039/C4CC08565E Geppert, 2011, Context-based identification of protein-protein interfaces and “hot-spot” residues, Chem. Biol., 18, 344, 10.1016/j.chembiol.2011.01.005 Cukuroglu, 2014, Hot spots in protein-protein interfaces: towards drug discovery, Prog. Biophys. Mol. Biol., 116, 165, 10.1016/j.pbiomolbio.2014.06.003 Liu, 2017, Small Molecules Engage Hot Spots through Cooperative Binding To Inhibit a Tight Protein-Protein Interaction, Biochemistry, 56, 1768, 10.1021/acs.biochem.6b01039 Fjell, 2012, Designing antimicrobial peptides: form follows function, Nat. Rev. Drug Discov., 11, 37, 10.1038/nrd3591 Bhardwaj, 2016, Accurate de novo design of hyperstable constrained peptides, Nature, 538, 329, 10.1038/nature19791 Eskandari, 2017, Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering, Adv. Drug Deliv. Rev., 110–111, 169, 10.1016/j.addr.2016.06.013 Huang, 2016, The coming of age of de novo protein design, Nature, 537, 320, 10.1038/nature19946 Chalkley, 2022, De novo metalloprotein design, Nat. Rev. Chem., 6, 31, 10.1038/s41570-021-00339-5 Polizzi, 2020, A defined structural unit enables de novo design of small-molecule-binding proteins, Science, 369, 1227, 10.1126/science.abb8330 Pandey, 2021, Role of Peptides in Diagnostics, Int. J. Mol. Sci., 22, 8828, 10.3390/ijms22168828 Ruoslahti, 2017, Tumor penetrating peptides for improved drug delivery, Adv. Drug Deliv. Rev., 110–111, 3, 10.1016/j.addr.2016.03.008 Timur, 2021, The role of peptide-based therapeutics in oncotherapy, J. Drug Target., 29, 1048, 10.1080/1061186X.2021.1906884 Wang, 2018, Structure-based design for binding peptides in anti-cancer therapy, Biomaterials, 156, 1, 10.1016/j.biomaterials.2017.11.024 Zong, 2016, Mitochondria and Cancer, Mol. Cell, 61, 667, 10.1016/j.molcel.2016.02.011 Bechara, 2013, Cell-penetrating peptides: 20 years later, where do we stand?, FEBS Lett., 587, 1693, 10.1016/j.febslet.2013.04.031 Ruseska, 2020, Internalization mechanisms of cell-penetrating peptides, Beilstein J. Nanotechnol., 11, 101, 10.3762/bjnano.11.10 Milletti, 2012, Cell-penetrating peptides: classes, origin, and current landscape, Drug Discov. Today, 17, 850, 10.1016/j.drudis.2012.03.002 Choi, 2011, Cell penetrating peptides for tumor targeting, Curr. Pharm. Biotechnol., 12, 1166, 10.2174/138920111796117391 Habault, 2019, Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies, Molecules, 24, 927, 10.3390/molecules24050927 Araste, 2018, Peptide-based targeted therapeutics: Focus on cancer treatment, J. Control. Release, 292, 141, 10.1016/j.jconrel.2018.11.004 Kapoor, 2012, TumorHoPe: A Database of Tumor Homing Peptides, PLoS One, 7, e35187, 10.1371/journal.pone.0035187 Wang, 2013, The functions and applications of RGD in tumor therapy and tissue engineering, Int. J. Mol. Sci., 14, 13447, 10.3390/ijms140713447 Wang, 2012, Development of NGR-based anti-cancer agents for targeted therapeutics and imaging, Anticancer Agents Med. Chem., 12, 76, 10.2174/187152012798764714 Song, 2019, Recent progress in LyP-1-based strategies for targeted imaging and therapy, Drug Deliv., 26, 363, 10.1080/10717544.2019.1587047 Okur, 2016, Targeting cancer cells via tumor-homing peptide CREKA functional PEG nanoparticles, Colloids Surf. b., 147, 191, 10.1016/j.colsurfb.2016.08.005 Enbäck, 2007, Tumour-homing peptides: tools for targeting, imaging and destruction, Biochem. Soc. Trans., 35, 780, 10.1042/BST0350780 Joyce, 2003, Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis, Cancer Cell, 4, 393, 10.1016/S1535-6108(03)00271-X Teesalu, 2009, C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration, Proc. Natl. Acad. Sci. u. s. a., 106, 16157, 10.1073/pnas.0908201106 Zhao, 2020, Targeting Strategies for Tissue-Specific Drug Delivery, Cell, 181, 151, 10.1016/j.cell.2020.02.001 Cheng, 2012, Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities, Science, 338, 903, 10.1126/science.1226338 Park, 2013, Facing the Truth about Nanotechnology in Drug Delivery, ACS Nano, 7, 7442, 10.1021/nn404501g Björnmalm, 2016, Increasing the Impact of Materials in and beyond Bio-Nano Science, J. Am. Chem. Soc., 138, 13449, 10.1021/jacs.6b08673 Ferrari, 2010, Frontiers in cancer nanomedicine: directing mass transport through biological barriers, Trends Biotechnol., 28, 181, 10.1016/j.tibtech.2009.12.007 Cho, 2008, Therapeutic nanoparticles for drug delivery in cancer, Clin. Cancer Res., 14, 1310, 10.1158/1078-0432.CCR-07-1441 Monopoli, 2012, Biomolecular coronas provide the biological identity of nanosized materials, Nat. Nanotechnol., 7, 779, 10.1038/nnano.2012.207 Chen, 2017, Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo, Nat. Nanotechnol., 12, 387, 10.1038/nnano.2016.269 Owens, 2006, Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles, Int. J. Pharm., 307, 93, 10.1016/j.ijpharm.2005.10.010 Wu, 2014, A facile route to tailoring peptide-stabilized gold nanoparticles using glutathione as a synthon, Molecules, 19, 6754, 10.3390/molecules19056754 Huang, 2013, Curb challenges of the “Trojan Horse” approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery, Adv. Drug Deliv. Rev., 65, 1299, 10.1016/j.addr.2012.11.007 Farkhani, 2014, Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules, Peptides, 57, 78, 10.1016/j.peptides.2014.04.015 Kristensen, 2016, Applications and Challenges for Use of Cell-Penetrating Peptides as Delivery Vectors for Peptide and Protein Cargos, Int. J. Mol. Sci., 17, 185, 10.3390/ijms17020185 Guidotti, 2017, Cell-Penetrating Peptides: From Basic Research to Clinics, Trends Pharmacol. Sci., 38, 406, 10.1016/j.tips.2017.01.003 Breger, 2017, Nanoparticle cellular uptake by dendritic wedge peptides: achieving single peptide facilitated delivery, Nanoscale, 9, 10447, 10.1039/C7NR03362A Di Pisa, 2015, Translocation Mechanism(s) of Cell-Penetrating Peptides: Biophysical Studies Using Artificial Membrane Bilayers, Biochemistry, 54, 194, 10.1021/bi501392n Sugahara, 2009, Tissue-penetrating delivery of compounds and nanoparticles into tumors, Cancer Cell, 16, 510, 10.1016/j.ccr.2009.10.013 Dehaini, 2016, Biomimetic strategies for targeted nanoparticle delivery, Bioeng. Transl. Med., 1, 30, 10.1002/btm2.10004 Manzari, 2021, Targeted drug delivery strategies for precision medicines, Nat. Rev. Mater., 6, 351, 10.1038/s41578-020-00269-6 Lee, 2007, Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display, Mol. Cancer Res., 5, 11, 10.1158/1541-7786.MCR-06-0069 Wei, 2017, Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy, Drug Deliv., 24, 681, 10.1080/10717544.2017.1309475 Geng, 2016, HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery, Theranostics, 6, 1261, 10.7150/thno.14302 Ding, 2017, HER2-positive breast cancer targeting and treatment by a peptide-conjugated mini nanodrug, Nanomedicine, 13, 631, 10.1016/j.nano.2016.07.013 Mu, 2015, Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells, Nanoscale, 7, 18010, 10.1039/C5NR04867B Arap, 2002, Targeting the prostate for destruction through a vascular address, Proc. Natl. Acad. Sci. u. s. a., 99, 1527, 10.1073/pnas.241655998 Yeh, 2016, Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer, Biomaterials, 99, 1, 10.1016/j.biomaterials.2016.05.015 Kolonin, 2004, Reversal of obesity by targeted ablation of adipose tissue, Nat. Med., 10, 625, 10.1038/nm1048 Azhdarinia, 2013, A peptide probe for targeted brown adipose tissue imaging, Nat. Commun., 4, 2472, 10.1038/ncomms3472 Field, 2015, Peptides for Specifically Targeting Nanoparticles to Cellular Organelles: Quo Vadis?, Acc. Chem. Res., 48, 1380, 10.1021/ar500449v Hayashi, 2007, A strategy for efficient cross-presentation of CTL-epitope peptides leading to enhanced induction of in vivo tumor immunity, J. Control. Release, 117, 11, 10.1016/j.jconrel.2006.10.011 Howes, 2014, Bionanotechnology.Colloidal nanoparticles as advanced biological sensors, Science, 346, 1247390, 10.1126/science.1247390 Loynachan, 2018, Platinum Nanocatalyst Amplification: Redefining the Gold Standard for Lateral Flow Immunoassays with Ultrabroad Dynamic Range, ACS Nano, 12, 279, 10.1021/acsnano.7b06229 Brangel, 2018, A Serological Point-of-Care Test for the Detection of IgG Antibodies against Ebola Virus in Human Survivors, ACS Nano, 12, 63, 10.1021/acsnano.7b07021 Eckert, 2013, Novel molecular and nanosensors for in vivo sensing, Theranostics, 3, 583, 10.7150/thno.6584 Rong, 2017, In Vivo Biosensing: Progress and Perspectives, ACS Sens., 2, 327, 10.1021/acssensors.6b00834 Nguyen, 2015, Nanoplasmonic biosensor: detection and amplification of dual bio-signatures of circulating tumor DNA, Biosens. Bioelectron., 67, 443, 10.1016/j.bios.2014.09.003 Wang, 2021, Supramolecular peptide nano-assemblies for cancer diagnosis and therapy: from molecular design to material synthesis and function-specific applications, J. Nanobiotehcnol., 19, 253, 10.1186/s12951-021-00999-x Yu, 2018, Polyrotaxane-based supramolecular theranostics, Nat. Commun., 9, 766, 10.1038/s41467-018-03119-w Zhu, 2019, Supramolecular peptide constructed by molecular Lego allowing programmable self-assembly for photodynamic therapy, Nat. Commun., 10, 2412, 10.1038/s41467-019-10385-9 Busseron, 2013, Supramolecular self-assemblies as functional nanomaterials, Nanoscale, 5, 7098, 10.1039/c3nr02176a Abbas, 2017, Self-assembled peptide- and protein-based nanomaterials for antitumor photodynamic and photothermal therapy, Adv. Mater., 29, 1605021, 10.1002/adma.201605021 Habibi, 2016, Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery, Nano Today, 11, 41, 10.1016/j.nantod.2016.02.004 Qi, 2018, Self-assembled peptide-based nanomaterials for biomedical imaging and therapy, Adv. Mater., 30, 1703444, 10.1002/adma.201703444 Kircher, 2012, Molecular imaging for personalized cancer care, Mol. Oncol., 6, 182, 10.1016/j.molonc.2012.02.005 R. Rebelo, A.I. Barbosa, S.C. Kundu, R.L. Reis, V.M. Correlo, Chapter 26 - Biodetection and sensing for cancer diagnostics, in: S.C. Kundu, R.L. Reis (Eds.), Biomaterials for 3D Tumor Modeling, Elsevier 2020, pp. 643-660. Pan, 2012, Nuclear-targeted drug delivery of TAT peptide-conjugated monodiperse mesoporous silica nanoparticles, J. Am. Chem. Soc., 134, 5722, 10.1021/ja211035w Yakati, 2022, Enhancing the anticancer effect of paclitaxel by using polymeric nanoparticles decorated with colorectal cancer targeting CPKSNNGVC-peptide, J. Drug Deliv. Sci. Tec., 68 Youssef, 2019, New Targeted Gold Nanorods for the Treatment of Glioblastoma by Photodynamic Therapy, J. Clin. Medicine., 8, 2205, 10.3390/jcm8122205 Tangthong, 2021, Water-Soluble Chitosan Conjugated DOTA-Bombesin Peptide Capped Gold Nanoparticles as a Targeted Therapeutic Agent for Prostate Cancer, Nanotechnol. Sci. Appl., 14, 69, 10.2147/NSA.S301942 Bechet, 2015, Multifunctional ultrasmall nanoplatforms for vascular-targeted interstitial photodynamic therapy of brain tumors guided by real-time MRI, Nanomed.: Nanotechnol, Biol. Med., 11, 657 Zhao, 2018, Photosensitive Nanoparticles Combining Vascular-Independent Intratumor Distribution and On-Demand Oxygen-Depot Delivery for Enhanced Cancer Photodynamic Therapy, Small., 14, e1703045, 10.1002/smll.201703045 Jiang, 2015, Actively targeting d -α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer, Nanoscale., 8, 3100, 10.1039/C5NR07724A Yan, 2016, Molecular imaging-guided photothermal/photodynamic therapy against tumor by iRGD-modified indocyanine green nanoparticles, J. Control. Release., 224, 217, 10.1016/j.jconrel.2015.12.050 Sukumar, 2019, Intranasal delivery of targeted polyfunctional gold–iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide, Biomaterials., 218, 10.1016/j.biomaterials.2019.119342 Shi, 2019, Magnetic Semiconductor Gd-Doping CuS Nanoparticles as Activatable Nanoprobes for Bimodal Imaging and Targeted Photothermal Therapy of Gastric Tumors, Nano Lett., 19, 937, 10.1021/acs.nanolett.8b04179 Fan, 2018, Near infrared fluorescent peptide nanoparticles for enhancing esophageal cancer therapeutic efficacy, Nat. Commun., 9, 2605, 10.1038/s41467-018-04763-y Zu, 2020, Peptide-enabled receptor-binding-quantum dots for enhanced detection and migration inhibition of cancer cells, J. Biomaterials Sci. Polym. Ed., 31, 1604, 10.1080/09205063.2020.1764191 Maraming, 2021, Conjugation with gold nanoparticles improves the stability of the KT2 peptide and maintains its anticancer properties, Rsc Adv., 12, 319, 10.1039/D1RA05980G Shah, 2014, Core-Shell Nanoparticle-Based Peptide Therapeutics and Combined Hyperthermia for Enhanced Cancer Cell Apoptosis, Acs Nano., 8, 9379, 10.1021/nn503431x Agemy, 2011, Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma, Proc. National Acad. Sci., 108, 17450, 10.1073/pnas.1114518108 Akrami, 2016, Tuning the anticancer activity of a novel pro-apoptotic peptide using gold nanoparticle platforms, Sci. Rep-Uk., 6, 31030, 10.1038/srep31030 Akrami, 2020, Potential anticancer activity of a new pro-apoptotic peptide-thioctic acid gold nanoparticle platform, Nanotechnology., 32 Niu, 2018, Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy, Biomaterials., 167, 132, 10.1016/j.biomaterials.2018.03.025 Limón, 2021, Enhanced cytotoxicity of highly water-soluble gold nanoparticle-cyclopeptide conjugates in cancer cells, Colloids Surfaces B Biointerfaces., 197, 10.1016/j.colsurfb.2020.111384 Kalmodia, 2017, Characterization and Molecular Mechanism of Peptide-Conjugated Gold Nanoparticle Inhibiting p53-HDM2 Interaction in Retinoblastoma, Mol. Ther. - Nucleic Acids., 9, 349, 10.1016/j.omtn.2017.10.012 Jiang, 2016, Enhanced in vivo antitumor efficacy of dual-functional peptide-modified docetaxel nanoparticles through tumor targeting and Hsp90 inhibition, J. Control Release., 221, 26, 10.1016/j.jconrel.2015.11.029 Luo, 2014, Multifunctional Enveloped Mesoporous Silica Nanoparticles for Subcellular Co-delivery of Drug and Therapeutic Peptide, Sci Rep-Uk., 4, 6064, 10.1038/srep06064 Chen, 2013, A new anti-cancer strategy of damaging mitochondria by pro-apoptotic peptide functionalized gold nanoparticles, Chem. Commun., 49, 6403, 10.1039/c3cc43283a Sharma, 2017, Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth, Nano Lett., 17, 1356, 10.1021/acs.nanolett.6b03815 Kwon, 2018, Thrombin-activatable fluorescent peptide incorporated gold nanoparticles for dual optical/computed tomography thrombus imaging, Biomaterials., 150, 125, 10.1016/j.biomaterials.2017.10.017 Hao, 2015, The tumor-targeting core–shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging, J. Control Release., 220, 545, 10.1016/j.jconrel.2015.11.016 Khemtong, 2009, In vivo Off-Resonance Saturation Magnetic Resonance Imaging of αvβ3-Targeted Superparamagnetic Nanoparticles, Cancer. Res., 69, 1651, 10.1158/0008-5472.CAN-08-3231 Sun, 2011, Tumor-Targeting Gold Particles for Dual Computed Tomography/Optical Cancer Imaging, Angew. Chem-Ger. Edit., 123, 9520, 10.1002/ange.201102892 Fan, 2016, Bioinspired fluorescent dipeptide nanoparticles for targeted cancer cell imaging and real-time monitoring of drug release, Nat. Nanotechnol., 11, 388, 10.1038/nnano.2015.312 Zhu, 2015, Dendrimer-entrapped gold nanoparticles modified with RGD peptide and alpha-tocopheryl succinate enable targeted theranostics of cancer cells, Colloids Surfaces B Biointerfaces., 133, 36, 10.1016/j.colsurfb.2015.05.040 Dalal, 2017, Multivalency Effect of TAT-Peptide-Functionalized Nanoparticle in Cellular Endocytosis and Subcellular Trafficking, J. Phys. Chem. b., 121, 2942, 10.1021/acs.jpcb.6b12182 Dai, 2018, Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors, Acs Nano., 12, 8423, 10.1021/acsnano.8b03900 Colombo, 2016, Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies, Nat. Commun., 7, 13818, 10.1038/ncomms13818 Yang, 2018, A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications, Acta. Biomater., 79, 306, 10.1016/j.actbio.2018.08.036 Zhao, 2015, Gold Nanoparticles Doped with (199) Au Atoms and Their Use for Targeted Cancer Imaging by SPECT, Adv. Healthc. Mater., 5, 928, 10.1002/adhm.201500992 Ren, 2020, Engineering NIR-IIb fluorescence of Er-based lanthanide nanoparticles for through-skull targeted imaging and imaging-guided surgery of orthotopic glioma, Nano Today., 34, 10.1016/j.nantod.2020.100905 Wang, 2011, Detection of Circulating Tumor Cells in Human Peripheral Blood Using Surface-Enhanced Raman Scattering Nanoparticles, Cancer Res., 71, 1526, 10.1158/0008-5472.CAN-10-3069 Cash, 2013, Phosphorescent Nanosensors for in Vivo Tracking of Histamine Levels, Anal. Chem., 85, 6312, 10.1021/ac400575u Ding, 2016, Construction of Epidermal Growth Factor Receptor Peptide Magnetic Nanovesicles with Lipid Bilayers for Enhanced Capture of Liver Cancer Circulating Tumor Cells, Anal. Chem., 88, 8997, 10.1021/acs.analchem.6b01443 Peng, 2017, Peptide-Functionalized Nanomaterials for the Efficient Isolation of HER2-Positive Circulating Tumor Cells, Acs. Appl. Mater. Inter., 9, 18423, 10.1021/acsami.7b03905 Dudani, 2016, Sustained-Release Synthetic Biomarkers for Monitoring Thrombosis and Inflammation Using Point-of-Care Compatible Readouts, Adv. Funct. Mater., 26, 2919, 10.1002/adfm.201505142 Gao, 2018, Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy, Sci. Transl. Med., 10, 10.1126/scitranslmed.aat0195 Kwong, 2013, Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease, Nat. Biotechnol., 31, 63, 10.1038/nbt.2464 Schuerle, 2016, Magnetically Actuated Protease Sensors for in Vivo Tumor Profiling, Nano Lett., 16, 6303, 10.1021/acs.nanolett.6b02670 Retout, 2022, Peptide-Conjugated Silver Nanoparticles for the Colorimetric Detection of the Oncoprotein Mdm2 in Human Serum, Chempluschem., 87, e202100450, 10.1002/cplu.202100450 Chen, 2022, A ratiometric fluorescent probe based on peptide modified MnFe2O4 nanoparticles for matrix metalloproteinase-7 activity detection in vitro and in vivo, Analyst., 147, 1581, 10.1039/D2AN00212D Santino, 2022, Preparation of Non-Toxic Fluorescent Peptide-Coated Silica/PEG Nanoparticles from Peptide-Block Copolymer Conjugates, Micro., 2, 240, 10.3390/micro2020016 Chang, 2023, Functional chromopeptide nanoarchitectonics: molecular design, self-assembly and biological applications, Chem. Soc. Rev., 52, 2688, 10.1039/D2CS00675H Chang, 2022, Amino-Acid-Encoded Supramolecular Photothermal Nanomedicine for Enhanced Cancer Therapy, Adv. Mater., 34, e2200139, 10.1002/adma.202200139 Zou, 2017, Biological Photothermal Nanodots Based on Self-Assembly of Peptide-Porphyrin Conjugates for Antitumor Therapy, J. Am. Chem. Soc., 139, 1921, 10.1021/jacs.6b11382 Zhao, 2019, Kinetically Controlled Self-Assembly of Phthalocyanine-Peptide Conjugate Nanofibrils Enabling Superlarge Redshifted Absorption, CCS Chem., 1, 173, 10.31635/ccschem.019.20180017 Xing, 2019, Self-Assembling Endogenous Biliverdin as a Versatile Near-Infrared Photothermal Nanoagent for Cancer Theranostics, Adv. Mater., 31, e1900822, 10.1002/adma.201900822 Li, 2021, Supramolecular Nanofibrils Formed by Coassembly of Clinically Approved Drugs for Tumor Photothermal Immunotherapy, Adv. Mater., 33, e2100595, 10.1002/adma.202100595 Li, 2018, Smart Peptide-Based Supramolecular Photodynamic Metallo-Nanodrugs Designed by Multicomponent Coordination Self-Assembly, J. Am. Chem. Soc., 140, 10794, 10.1021/jacs.8b04912 Geng, 2021, Biomimetic Nanozymes Based on Coassembly of Amino Acid and Hemin for Catalytic Oxidation and Sensing of Biomolecules, Small., 17, e2008114, 10.1002/smll.202008114 Ma, 2022, Orally administered covalently-assembled antioxidative peptide nanoparticles for inflammatory bowel disease therapy, J. Colloid Interface Sci., 626, 156, 10.1016/j.jcis.2022.06.088 Ren, 2022, Enzyme-driven oxygen-fuelled pathway selectivity of tyrosine-containing peptide oxidation evolution, Chem. Eng. J., 450, 10.1016/j.cej.2022.138293 Hong, 2021, Supramolecular Nanodrugs Based on Covalent Assembly of Therapeutic Peptides toward In Vitro Synergistic Anticancer Therapy, ChemMedChem., 16, 2381, 10.1002/cmdc.202100236 Brito, 2021, Smart magnetic resonance imaging-based theranostics for cancer, Theranostics, 11, 8706, 10.7150/thno.57004 Jeong, 2018, Theranostics and contrast agents for magnetic resonance imaging, Biomater. Res., 22, 20, 10.1186/s40824-018-0130-1 Ariga, 2011, Nanoarchitectonics: a conceptual paradigm for design and synthesis of dimension-controlled functional nanomaterials, J. Nanosci. Nanotechnol., 11, 1, 10.1166/jnn.2011.3839 Ariga, 2015, Nanoarchitectonics: a new materials horizon for nanotechnology, Mater. Horiz., 2, 406, 10.1039/C5MH00012B Chen, 2017, Rethinking cancer nanotheranostics, Nat. Rev. Mater., 2, 17024, 10.1038/natrevmats.2017.24 Kim, 2023, Wearable and implantable bioelectronics as eco-friendly and patient-friendly integrated nanoarchitectonics for next-generation smart healthcare technology, EcoMat, 5, 10.1002/eom2.12356 Sarhadi, 2022, Molecular Biomarkers in Cancer, Biomolecules, 12, 1021, 10.3390/biom12081021 Anderson, 2020, The tumor microenvironment, Current Biology, 30, R921, 10.1016/j.cub.2020.06.081 Baghban, 2020, Tumor microenvironment complexity and therapeutic implications at a glance, Cell Commun. Signal., 18, 59, 10.1186/s12964-020-0530-4 Zhang, 2020, The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications, Cell Mol. Immunol., 17, 807, 10.1038/s41423-020-0488-6 Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Hanahan, 2022, Hallmarks of Cancer: New Dimensions, Cancer Discov., 12, 31, 10.1158/2159-8290.CD-21-1059 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 d'Angelo, 2019, Theranostic Nanomedicine for Malignant Gliomas, Front. Bioeng. Biotechnol., 7, 325, 10.3389/fbioe.2019.00325 Tang, 2019, Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics, Chem. Soc. Rev., 48, 2967, 10.1039/C8CS00805A Bhojani, 2010, Targeted Imaging and Therapy of Brain Cancer Using Theranostic Nanoparticles, Mol. Pharmaceutics, 7, 1921, 10.1021/mp100298r Zhang, 2022, Functionalization of Nanomaterials for Skin Cancer Theranostics, Front. Bioeng. Biotechnol., 10 Madamsetty, 2020, Functionalization of Nanomaterials and Their Application in Melanoma Cancer Theranostics, ACS Biomater. Sci. Eng., 6, 167, 10.1021/acsbiomaterials.9b01426 Guo, 2021, Signal pathways of melanoma and targeted therapy, Signal Transduct, Target. Ther., 6, 424 Oh, 2020, HER2-targeted therapies – a role beyond breast cancer, Nat. Rev. Clin. Oncol., 17, 33, 10.1038/s41571-019-0268-3 Tadić, 2012, Highly crystalline superparamagnetic iron oxide nanoparticles (SPION) in a silica matrix, J. Alloys Compd., 525, 28, 10.1016/j.jallcom.2012.02.056 Hong, 2009, Molecular Imaging with Single-Walled Carbon Nanotubes, Nano Today, 4, 252, 10.1016/j.nantod.2009.04.002 Hussain, 2001, Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics, Adv. Drug Deliv. Rev., 50, 107, 10.1016/S0169-409X(01)00152-1 Sercombe, 2015, Advances and Challenges of Liposome Assisted Drug Delivery, Front. Pharmacol., 6, 10.3389/fphar.2015.00286 Patra, 2018, Nano based drug delivery systems: recent developments and future prospects, J. Nanobiotechnol., 16, 71, 10.1186/s12951-018-0392-8 Volpatti, 2020, Glucose-Responsive Nanoparticles for Rapid and Extended Self-Regulated Insulin Delivery, ACS Nano, 14, 488, 10.1021/acsnano.9b06395 Zhang, 2020, Microfluidic-assisted polymer-protein assembly to fabricate homogeneous functionalnanoparticles, Mater. Sci. Eng. c., 111, 10.1016/j.msec.2020.110768 Yang, 2019, Gold nanoparticle based photothermal therapy: Development and application for effective cancer treatment, Sustain. Mater. Technol., 22, e00109 Wang, 2020, Gold Nanoshell-Linear Tetrapyrrole Conjugates for Near Infrared-Activated Dual Photodynamic and Photothermal Therapies, ACS Omega, 5, 926, 10.1021/acsomega.9b04150 Arias, 2018, Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity, Antibiotics (basel), 7, 46, 10.3390/antibiotics7020046 Ma, 2016, Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives, Small, 12, 4936, 10.1002/smll.201600635 Bhatia, 2022, Cancer nanomedicine, Nat. Rev. Cancer, 22, 550, 10.1038/s41568-022-00496-9 Gautam, 2012, CPPsite: a curated database of cell penetrating peptides, Database (oxford), bas015 Saar, 2005, Cell-penetrating peptides: a comparative membrane toxicity study, Anal. Biochem., 345, 55, 10.1016/j.ab.2005.07.033 Yang, 2021, Bottom-up de novo design of functional proteins with complex structural features, Nat. Chem. Biol., 17, 492, 10.1038/s41589-020-00699-x Ovchinnikov, 2021, Structure-based protein design with deep learning, Curr. Opin. Chem. Biol., 65, 136, 10.1016/j.cbpa.2021.08.004 Grigoryan, 2011, Computational Design of Virus-Like Protein Assemblies on Carbon Nanotube Surfaces, Science, 332, 1071, 10.1126/science.1198841 Brunette, 2015, Exploring the repeat protein universe through computational protein design, Nature, 528, 580, 10.1038/nature16162 Chevalier, 2017, Massively parallel de novo protein design for targeted therapeutics, Nature, 550, 74, 10.1038/nature23912 Boisguerin, 2021, Peptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery, Biomedicines, 9, 583, 10.3390/biomedicines9050583 Vanhee, 2011, Computational design of peptide ligands, Trends Biotechnol., 29, 231, 10.1016/j.tibtech.2011.01.004 Kim, 2022, Supramolecular assembly of protein building blocks: from folding to function, Nano Converg., 9, 4, 10.1186/s40580-021-00294-3 Kuhlman, 2019, Advances in protein structure prediction and design, Nat. Rev. Mol. Cell Biol., 20, 681, 10.1038/s41580-019-0163-x Berman, 2000, The Protein Data Bank, Nucleic Acids Res., 28, 235, 10.1093/nar/28.1.235 Vanhee, 2009, Protein-peptide interactions adopt the same structural motifs as monomeric protein folds, Structure, 17, 1128, 10.1016/j.str.2009.06.013 Kuhlman, 2003, Design of a novel globular protein fold with atomic-level accuracy, Science, 302, 1364, 10.1126/science.1089427 Huang, 2011, RosettaRemodel: A Generalized Framework for Flexible Backbone Protein Design, PLoS One, 6, e24109, 10.1371/journal.pone.0024109 Harbury, 1998, High-resolution protein design with backbone freedom, Science, 282, 1462, 10.1126/science.282.5393.1462 Thomson, 2014, Computational design of water-soluble α-helical barrels, Science, 346, 485, 10.1126/science.1257452 Grigoryan, 2011, Probing designability via a generalized model of helical bundle geometry, J Mol Biol, 405, 1079, 10.1016/j.jmb.2010.08.058 No, 2017, Nature-Inspired Construction of Two-Dimensionally Self-Assembled Peptide on Pristine Graphene, J. Phys. Chem. Lett., 8, 3734, 10.1021/acs.jpclett.7b00996 Kim, 2017, Highly sensitive graphene biosensor by monomolecular self-assembly of receptors on graphene surface, Appl. Phys. Lett., 110, 10.1063/1.4983084 Bhatia, 2016, 33 Jumper, 2021, Highly accurate protein structure prediction with AlphaFold, Nature, 596, 583, 10.1038/s41586-021-03819-2 S. Karandikar, A. Mirani, V. Waybhase, V.B. Patravale, S. Patankar, Chapter 10 Nanovaccines for oral delivery-formulation strategies and challenges, Nanostructures for Oral Medicine 2017, pp. 263-293. Lu, 2021, Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines, Vaccines (basel), 9, 563, 10.3390/vaccines9060563 Spicer, 2018, Achieving Controlled Biomolecule-Biomaterial Conjugation, Chem. Rev., 118, 7702, 10.1021/acs.chemrev.8b00253 J.I. Sanchez-Villamil, D. Tapia, A.G. Torres, Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7, mBio 10(4) (2019) e01869-19. https://doi.org/10.1128/mBio.01869-19. Tsuchikama, 2018, Antibody-drug conjugates: recent advances in conjugation and linker chemistries, Protein Cell, 9, 33, 10.1007/s13238-016-0323-0 Hossain, 2019, Liposomal Fc Domain Conjugated to a Cancer Vaccine Enhances Both Humoral and Cellular Immunity, ACS Omega, 4, 5204, 10.1021/acsomega.9b00029 Slütter, 2010, Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?, Mol. Pharm., 7, 2207, 10.1021/mp100210g Hoppenz, 2020, Peptide-drug conjugates and their targets in advanced cancer therapies, Front. Chem., 8, 10.3389/fchem.2020.00571 Wang, 2010, The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies, J. Am. Chem. Soc., 132, 11306, 10.1021/ja1043177 Benachour, 2012, Multifunctional peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI, Theranostics, 2, 889, 10.7150/thno.4754 Busch, 2019, ACS Omega, 4, 15269, 10.1021/acsomega.9b02276 Yang, 2015, Anti-PEG immunity: emergence, characteristics, and unaddressed questions, Wiley Interdiscip. Rev. Nanomed., 7, 655, 10.1002/wnan.1339 Sun, 2015, Tunable synthesis of self-assembled cyclic peptide nanotubes and nanoparticles, Soft Matter, 11, 3822, 10.1039/C5SM00533G Heemels, 2016, Neurodegenerative diseases, Nature, 539, 179, 10.1038/539179a Hansson, 2021, Biomarkers for neurodegenerative diseases, Nat. Med., 27, 954, 10.1038/s41591-021-01382-x Oller-Salvia, 2016, Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery, Chem. Soc. Rev., 45, 4690, 10.1039/C6CS00076B Pardridge, 2012, Drug Transport across the Blood-Brain Barrier, J. Cereb. Blood Flow Metab., 32, 1959, 10.1038/jcbfm.2012.126 Furtado, 2018, Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases, Adv. Mater., 30, 1801362, 10.1002/adma.201801362 Sapsford, 2013, Functionalizing Nanoparticles with Biological Molecules: Developing Chemistries that Facilitate Nanotechnology, Chem. Rev., 113, 1904, 10.1021/cr300143v